Wiley at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

Wiley takes part in 2 sessions at BioTechX Europe 2026 in Basel, and exhibits at Booth 202. Its program centres on the role of published research in AI for drug R&D. It argues that peer-reviewed science is the missing base for AI that R&D teams can trust, and joins Bayer, Servier and Roche on turning data and regulatory complexity into better decisions.

OrganizationBioTechX Europe 2026 Attendance
Wiley
Hoboken, NJ
wiley.com
Other servicesPlatinum sponsor
Scientific publisher providing research content and data to life sciences organizations.
Booth
Exhibiting at Booth 202
Panel
Tue Oct 6
17:25
Autonomous R&D: Transforming Data and Regulatory Complexity into a Strategic Decision Advantage
Digital Transformation · with Bayer, Servier, Roche
Talk
Wed Oct 7
15:50
From Data Flood to Decision: Why Peer-Reviewed Science is the Missing Foundation for Trusted AI in R&D
Large Language models

Explore the full BioTechX Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full BioTechX Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Wiley

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or BioTechX. Submit a correction